SIGA Technologies, Inc.
SIGA
Rank in Stocks
#15976
SIGA Technologies, Inc. is a pharmaceutical company with commercialized... SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Share Price
$3.26
Last synced: 2026-11-09
Market Cap
$234.23M
Change (1 day)
5.16%
Change (1 year)
-48.17%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SIGA Technologies, Inc. (SIGA)
Category
Healthcare
Operating Margin for SIGA Technologies, Inc. (SIGA)
Operating Margin as of November 2026 TTM: -20.76%
According to SIGA Technologies, Inc.'s latest financial reports, its current operating margin (TTM) is -20.76%. At the end of 2025 the company had an operating margin of 25.05%.
Operating Margin history for SIGA Technologies, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -20.76% | -182.87% |
| 2025 | 25.05% | -50.35% |
| 2024 | 50.45% | -15.58% |
| 2023 | 59.76% | 55.02% |
| 2022 | 38.55% | -42.16% |
| 2021 | 66.65% | -1.43% |
| 2020 | 67.62% | -879.03% |
| 2019 | -8.68% | -111.66% |
| 2018 | 74.44% | -148.45% |
| 2017 | -153.63% | -25.76% |
| 2016 | -206.94% | -45.34% |
| 2015 | -378.59% | -94.33% |
| 2014 | -6,677.64% | 1,467.26% |
| 2013 | -426.07% | 69.61% |
| 2012 | -251.21% | 1.87% |
| 2011 | -246.60% | 272.45% |
| 2010 | -66.21% | -23.02% |
| 2009 | -86.01% | -20.60% |
| 2008 | -108.32% | -2.77% |
| 2007 | -111.41% | 18.72% |
| 2006 | -93.84% | 214.16% |
| 2005 | -29.87% | -94.19% |
| 2004 | -513.72% | -29.00% |
| 2003 | -723.60% | -25.93% |
| 2002 | -976.95% | 247.29% |
| 2001 | -281.31% | -80.81% |
| 2000 | -1,466.21% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.93% |
DE
|
|
| 19.68% | -100.95% |
DE
|
|
| 13.26% | -100.64% |
JP
|
|
| 17.08% | -100.82% |
CH
|
|
| 14.92% | -100.72% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SIGA Technologies, Inc.'s operating margin
What is SIGA Technologies, Inc.'s operating margin?
SIGA Technologies, Inc.'s operating margin is -20.76%, as of Nov 2026.
What was SIGA Technologies, Inc.'s operating margin in 2025?
In 2025, SIGA Technologies, Inc.'s operating margin was 25.05%, compared with 50.45% in 2024.
How has SIGA Technologies, Inc.'s operating margin changed since 2020?
From 2020 to 2025, SIGA Technologies, Inc.'s operating margin was highest in 2020 (67.62%) and lowest in 2025 (25.05%).
How does SIGA Technologies, Inc.'s operating margin compare with similar companies?
SIGA Technologies, Inc.'s operating margin (-20.76%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.